Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a national provider of patient-centered, healthcare-at-home solutions, and this news page focuses on its latest corporate and financial developments. The company’s public announcements describe a business centered on home medical equipment, medical supplies, and related services, organized into four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home.
Visitors to this AdaptHealth news feed can review press releases on quarterly earnings, financial guidance, capital structure updates, and ratings actions. Recent communications have included results for the second and third quarters, commentary on net revenue, net income, cash flow from operations, and the use of non-GAAP metrics such as Adjusted EBITDA, free cash flow, and organic revenue, as described by the company.
The news flow also covers strategic and operational updates. AdaptHealth has announced a definitive agreement to serve as the exclusive provider of home medical equipment and supplies for a major national healthcare system under a capitated model, as well as additional capitated agreements with payors. The company has reported dispositions of certain assets in its Wellness at Home segment and highlighted digital patient engagement initiatives through its own tools.
In addition, this page aggregates AdaptHealth’s disclosures about participation in healthcare and finance conferences, earnings release dates, and investor conference calls. For investors and observers tracking AHCO, the news stream provides direct access to the company’s own descriptions of its performance, partnerships, and healthcare-at-home operations across sleep, respiratory, diabetes, and wellness product categories.
AdaptHealth Corp. (NASDAQ: AHCO) has initiated a public offering of 7,000,000 shares of its Class A Common Stock, with an additional 1,000,000 shares offered by certain selling stockholders. The offering may also include a 30-day option for underwriters to purchase up to 1,200,000 additional shares. Proceeds will primarily finance the acquisition of AeroCare Holdings, with the remainder allocated for general corporate purposes. The company will not gain any proceeds from shares sold by selling stockholders, and the offering's completion is independent of the AeroCare acquisition.
AdaptHealth Corp. (NASDAQ: AHCO) has priced a $500 million offering of 4.625% senior notes due 2029. Proceeds will fund the acquisition of AeroCare Holdings, with completion expected in Q1 2021, pending customary conditions. If the acquisition isn’t finalized by May 31, 2021, the notes will be redeemed at 100% of their principal. The offering is exclusively for qualified institutional buyers and has not been registered under the Securities Act. AdaptHealth serves approximately 1.8 million patients across 41 states, providing essential home healthcare equipment and services.
AdaptHealth Corp. (NASDAQ: AHCO) has initiated an offering of $500 million senior notes due 2029 through its subsidiary, AdaptHealth LLC. The proceeds will be held in escrow until the completion of the acquisition of AeroCare Holdings, Inc. The acquisition is projected to close in Q1 2021, with potential redemption of the notes if not completed by May 31, 2021. The notes will be guaranteed by various subsidiaries, and are offered exclusively to qualified institutional buyers. This press release does not constitute an offer to sell securities.
AdaptHealth Corp. (NASDAQ: AHCO) has announced its decision to acquire AeroCare Holdings, Inc. for approximately $2.0 billion. The deal includes $1.1 billion in cash and 31 million shares of AdaptHealth common stock. This merger is expected to enhance AdaptHealth's geographic presence, reaching 47 out of 48 continental US states and solidifying partnerships with healthcare providers. The company also raised its 2021 financial guidance significantly, projecting net revenues of $2.05 billion to $2.20 billion and Adjusted EBITDA of $480 million to $515 million.
AdaptHealth Corp. (NASDAQ: AHCO) reported strong financial results for Q3 2020, with net revenue of $284.4 million, up 108% year-over-year. The company expanded through acquisitions, enhancing its diabetes management and home medical equipment operations. Despite a net loss of $2.5 million, adjusted EBITDA grew significantly to $53.2 million compared to $31.7 million in Q3 2019. The company increased its 2020 revenue guidance to $1.00-$1.04 billion and provided a strong outlook for 2021, projecting $1.30-$1.40 billion in revenue. CEO Luke McGee highlighted the team's dedication amidst challenges.
AdaptHealth Corp. (NASDAQ: AHCO) has announced the release of its financial results for the third quarter ended September 30, 2020, scheduled for November 4, 2020, before market opening. The management will host a conference call at 8:30 am ET on the same day to discuss the results and business activities. The company serves approximately 1.6 million patients annually through its network of 220 locations across 38 states, providing a range of home medical equipment and services, including sleep therapy and oxygen therapy.